Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 3361 AL 3375

Efficacy and safety of standardized extract of Trigonella foenum-graecum L seeds as an adjuvant to L-Dopa in the management of patients with Parkinson's disease

Nathan J, Panjwani S, Mohan V, Joshi V, Thakurdesai PA.

Phytother Res. 2014 Feb;28(2):172-8. doi: 10.1002/ptr.4969. Epub 2013 Mar 20.

Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding?

Fiandaca MS, Federoff HJ.

Exp Neurol. 2014 Jun;256:117-25. doi: 10.1016/j.expneurol.2013.03.014. Epub 2013 Mar 22.

Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Am J Geriatr Psychiatry. 2014 Jun;22(6):580-6. doi: 10.1016/j.jagp.2012.11.001. Epub 2013 Apr 9.

Effectiveness of multidisciplinary interventions to improve the quality of life for people with Parkinson's disease: a systematic review

Tan SB, Williams AF, Kelly D.

Int J Nurs Stud. 2014 Jan;51(1):166-74. doi: 10.1016/j.ijnurstu.2013.03.009. Epub 2013 Apr 20.

Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism

Baizabal-Carvallo JF, Jankovic J.

Neuromodulation. 2014 Jan;17(1):104-6. doi: 10.1111/ner.12071. Epub 2013 May 10.

Risk prediction and treatment monitoring are crucial for prevention and management of compulsive dopamine use in Parkinson's disease

van den Heuvel OA.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):244. doi: 10.1136/jnnp-2013-305378. Epub 2013 May 14.

Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment

Benbir G, Ertan S, Ozekmekci S.

Presse Med. 2014 Jan;43(1):83-5. doi: 10.1016/j.lpm.2013.01.067. Epub 2013 May 18.

Metalloporphyrins as therapeutic catalytic oxidoreductants in central nervous system disorders

Sheng H, Chaparro RE, Sasaki T, Izutsu M, Pearlstein RD, Tovmasyan A, Warner DS.

Antioxid Redox Signal. 2014 May 20;20(15):2437-64. doi: 10.1089/ars.2013.5413. Epub 2013 Oct 1.

Oscillations and the basal ganglia: motor control and beyond

Brittain JS, Brown P.

Neuroimage. 2014 Jan 15;85 Pt 2(Pt 2):637-47. doi: 10.1016/j.neuroimage.2013.05.084. Epub 2013 May 25.

Cycads and their association with certain neurodegenerative diseases

Rivadeneyra-Domínguez E, Rodríguez-Landa JF.

Neurologia. 2014 Nov-Dec;29(9):517-22. doi: 10.1016/j.nrl.2013.03.005. Epub 2013 May 30.

A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets

Ramsey CP, Tansey MG.

Exp Neurol. 2014 Jun;256:126-32. doi: 10.1016/j.expneurol.2013.05.014. Epub 2013 May 28.

Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation

Carney RM, Kohli MA, Kunkle BW, Naj AC, Gilbert JR, Züchner S, Pericak-Vance MA.

Alzheimers Dement. 2014 May;10(3):360-5. doi: 10.1016/j.jalz.2013.02.011. Epub 2013 May 30.

The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease

Rideout HJ, Stefanis L.

Neurochem Res. 2014;39(3):576-92. doi: 10.1007/s11064-013-1073-5. Epub 2013 Jun 1.

Mitochondrial complex enzyme activities and cytochrome C expression changes in multiple sclerosis

Iñarrea P, Alarcia R, Alava MA, Capablo JL, Casanova A, Iñiguez C, Iturralde M, Larrodé P, Martín J, Mostacero E, Ara JR.

Mol Neurobiol. 2014 Feb;49(1):1-9. doi: 10.1007/s12035-013-8481-z. Epub 2013 Jun 13.

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes

Niranjan R.

Mol Neurobiol. 2014 Feb;49(1):28-38. doi: 10.1007/s12035-013-8483-x. Epub 2013 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias